Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Drugmakers Must Protect Their Trade Secrets

Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Drugmakers Must Protect Their Trade Secrets

Article excerpt

A recent editorial on drug price legislation ("Prescription for Clarity: Vermont Lawmakers Shed Light on High Drug Prices," May 17) confused key issues relating to drug prices, and the Vermont legislation is no antidote for patients or highly innovative manufacturers.

Manufacturers understand the need to reduce health care costs, but we have serious concerns related to the long-term implications of pharmaceutical pricing transparency proposals. Protection of trade secrets and intellectual property is a necessity for manufacturers to succeed in today's intensely competitive global marketplace. No industry should be forced to turn over highly sensitive, proprietary information to any government - state or federal.

Trade secrets, which include pricing information, are protected by both federal and state laws. Any proposal at the state or federal level that requires manufacturers to turn over and reveal highly sensitive operational information - such as pricing on specific products, marketing costs, planned research investments, anticipated profits and manufacturing production costs - sets a dangerous precedent that will deliver chilling impacts to our global competitiveness and prospects for economic growth. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.